Analysis of blood samples taken six weeks post-vaccination with virosome-gp41 peptides have revealed the presence of anti-gp41 antibodies (IgG and IgA), confirming previous data from rabbit models. The
The first study was a phase IIa study of TA-CD conducted by Dr Margaret Haney, associate professor of Clinical Neuroscience at Columbia University. The study looked at the
The company will work with Dr Steven Rosenberg, chief, Surgery Branch, who has identified and characterized a number of melanoma tumor-associated antigens and has developed a lymphodepleting non-myeloablative
Shares in Evotec, which could receive milestone payments of more than E100 million as a result of the collaboration, rose as much as 15% after the news of
This expands the indication for the drug, which is marketed by Roche in Europe, making it available for use in the treatment of second-line as well as the
The proof-of-concept trial of the drug, PRS-211,375, will be conducted among healthy subjects experiencing pain following third molar dental extraction. The single-center, randomized, double-blinded, single-dose intravenous study will
Cyanokit is in development for the treatment of known or suspected cyanide poisoning and is currently marketed in France by another Merck KGaA affiliate, Merck Sante. The FDA
Praecis will work with the FDA to discontinue the limited distribution of the product in the United States as soon as possible and will no longer pursue commercialization
The compound, AEOL 11207, has shown potential in preclinical testing as a once-every-other-day oral therapeutic treatment option for a number of CNS disorders, most likely Parkinson's disease. However,
Lipodystrophy is a condition dominated by fat redistribution, particularly visceral fat accumulation and subcutaneous fat loss. No drugs are currently approved for the treatment of HIV lipodystrophy. According
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.